62 related articles for article (PubMed ID: 35831424)
1. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy and intensity-modulated radiotherapy alone for stage II nasopharyngeal carcinoma.
Chen KH; Zhu XD; Li L; Qu S; Liang ZQ; Liang X; Pan XB; Liang ZG; Jiang YM
Oncotarget; 2016 Oct; 7(42):69041-69050. PubMed ID: 27634892
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
Yang Z; Zuo Q; Liu R; Wu H; Xiong L; Jia J; Xiang Z
BMC Cancer; 2023 Nov; 23(1):1140. PubMed ID: 37996813
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.
Özkaya Toraman K; Meral R; Karadeniz AN; Kaval G; Başaran M; Ekenel M; Altun M
J Chemother; 2024 Apr; 36(2):133-142. PubMed ID: 37211862
[TBL] [Abstract][Full Text] [Related]
4. Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
Zhang Y; Fan S; Shan M; Zou W; Feng Y; Hou T; Liu X; Wang J
Sci Rep; 2023 Jun; 13(1):9352. PubMed ID: 37291330
[TBL] [Abstract][Full Text] [Related]
5. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach.
Lu T; Xu H; Huang W; Zong J; Pan C; Huang C; Xiao Y; Chen B; Li J; Pan J; Lin S; Guo F; Guo Q
Radiother Oncol; 2023 Aug; 185():109716. PubMed ID: 37207875
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers.
Kubo K; Murakami Y; Kenjo M; Imano N; Takeuchi Y; Nishibuchi I; Kimura T; Kawahara D; Ueda T; Takeno S; Nagata Y
J Radiat Res; 2020 Jul; 61(4):554-562. PubMed ID: 32548612
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
Wang L; Liu D; Wei D
Comput Math Methods Med; 2022; 2022():5145549. PubMed ID: 36060662
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab Plus Concurrent Radiotherapy in Patients With Nasopharyngeal Carcinoma.
Yamauchi M; Sato Y; Ishida T; Minesaki A; Shimazaki E; Kuratomi Y
In Vivo; 2023; 37(5):2224-2228. PubMed ID: 37652522
[TBL] [Abstract][Full Text] [Related]
9. Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
Cui L; Chen Z; Zeng F; Jiang X; Han X; Yuan X; Wu S; Feng H; Lin D; Lu W; Liu X; Peng X; Yu B
BMC Cancer; 2023 Nov; 23(1):1146. PubMed ID: 38007428
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma.
Wang F; Jiang C; Ye Z; Sun Q; Liu T; Xu M; Wu P; Shi K; Long B; Fu Z; Jiang Y
Transl Oncol; 2018 Apr; 11(2):338-345. PubMed ID: 29425953
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiotherapy for nasopharyngeal carcinoma in Japan: analysis of cases in the National Head and Neck Cancer Registry from 2011 to 2014.
Koide Y; Kodaira T; Kitayama M; Kawakita D; Kirita T; Yoshimoto S; Nakamizo M; Nibu KI
Jpn J Clin Oncol; 2024 Jan; 54(1):54-61. PubMed ID: 37781753
[TBL] [Abstract][Full Text] [Related]
12. Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
Hahn E; Ng WT
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):925-927. PubMed ID: 37838451
[No Abstract] [Full Text] [Related]
13. [Treatment advances in locoregionally advanced nasopharyngeal carcinoma:2023 ASCO Voice of China].
Ding X; Chen MY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Oct; 58(10):1028-1031. PubMed ID: 37840171
[TBL] [Abstract][Full Text] [Related]
14. Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.
Zhang LL; Chen X; Huang YY; Liang CX; Qiang MY; Cai ZC; Zhan ZJ; Deng Y; Zhou JY; Huang HY; Guo X; Lv X
Cancer Med; 2023 Jul; 12(13):14084-14093. PubMed ID: 37212462
[TBL] [Abstract][Full Text] [Related]
15. Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
Mabuchi S; Kimura T
Chemother Res Pract; 2011; 2011():963159. PubMed ID: 22312560
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9869683. PubMed ID: 37416124
[TBL] [Abstract][Full Text] [Related]
17. Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients.
Deng C; Zhang N; Jiang S; Zhang H; Ma J; Zou W; Liu X; Hu C; Hou T
Sci Rep; 2022 Jul; 12(1):11978. PubMed ID: 35831424
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.
Liang X; Liu Q; Yao W; Yang S
Medicine (Baltimore); 2022 Dec; 101(49):e31187. PubMed ID: 36626436
[TBL] [Abstract][Full Text] [Related]
19. Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
Tang QN; Liu LT; Qi B; Guo SS; Luo DH; Sun R; Sun XS; Chen DP; Guo L; Mo HY; Wang P; Liu SL; Liang YJ; Li XY; Yang ZC; Chen QY; Mai HQ; Tang LQ
JAMA Netw Open; 2021 Dec; 4(12):e2138470. PubMed ID: 34928359
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
